Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
News Wire ~ 3rd Party Press Release
295 POSTS
0 COMMENTS
Amulet Launches to Bring Powerful Detection Out of the Lab and Into the Hands...
News Wire ~ 3rd Party Press Release
-
2022/05/18
Signature consumer wearable will begin shipping this summer.
Prota Therapeutics Achieves 51% Peanut Allergy Remission Rate in Kids with OIT Candidate
News Wire ~ 3rd Party Press Release
-
2022/05/16
Children's ability to eat peanut freely and safely delivers meaningful improvement in quality of life for families and patients.
FDA Accepts Dupixent® (dupilumab) for Priority Review in Patients Aged 12 Years and Older...
News Wire ~ 3rd Party Press Release
-
2022/04/12
If approved, Dupixent would be the first medicine available in the U.S. indicated to treat eosinophilic esophagitis.
Food Allergy Research and Education Names Permanent CEO
News Wire ~ 3rd Party Press Release
-
2022/04/11
Extensive Search Culminates in New Leadership for Flagship Food Allergy Organization.
Plant Compound Shows Promise for Alleviating Food Allergies
News Wire ~ 3rd Party Press Release
-
2022/04/04
Study uncovers new drug targets for treating other allergic disorders.
New Blood Test Simplifies the Diagnosis of Allergies and Can Help Predict the Success...
News Wire ~ 3rd Party Press Release
-
2022/03/24
Test is painless, safe, reliable and scalable.
Adamis Issues Recall of SYMJEPI Emergency Epinephrine Device for Potential Manufacturing Defect
News Wire ~ 3rd Party Press Release
-
2022/03/22
Specific batches identified in the article are being recalled.
Sublingual Epinephrine for Anaphylaxis Receives Fast Track Designation from FDA
News Wire ~ 3rd Party Press Release
-
2022/03/18
AQST-109 is the first orally delivered epinephrine-based product candidate for the emergency treatment of allergic reactions including anaphylaxis.
FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven Peanut Allergy Therapy
News Wire ~ 3rd Party Press Release
-
2022/03/04
Phase 2 study of candidate from Aravax will commence in the US and Australia.
Positive Early Results with Fecal Microbiota Therapy for Peanut-Allergic Patients
News Wire ~ 3rd Party Press Release
-
2022/02/28
Encapsulated stool from non-allergic donors alters the immune system and increases tolerance to peanuts.
1
2
3
...
30
Page 1 of 30